AstraZeneca to Acquire Alexion: Greater Scientific Presence In Immunology by Adding Alexion’s Innovative Complement-technology Platforms and Strong Pipeline
December 12, 2020 AstraZeneca announced today they have entered into a definitive agreement for AstraZeneca to acquire Alexion. Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary…